Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

Bioprofile analysis: a new approach for the analysis of biomedical data in Alzheimer's disease.

Escudero J, Ifeachor E, Zajicek JP; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2012;32(4):997-1010. doi: 10.3233/JAD-2012-121024.

PMID:
22886027
[PubMed - indexed for MEDLINE]
2.

[Neuropsychological impairment in the early Alzheimer's disease].

Traykov L, Rigaud AS, Cesaro P, Boller F.

Encephale. 2007 May-Jun;33(3 Pt 1):310-6. Review. French.

PMID:
17675928
[PubMed - indexed for MEDLINE]
3.

Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.

Levey A, Lah J, Goldstein F, Steenland K, Bliwise D.

Clin Ther. 2006 Jul;28(7):991-1001. Review.

PMID:
16990077
[PubMed - indexed for MEDLINE]
4.

Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans.

Aisen PS, Petersen RC, Donohue MC, Gamst A, Raman R, Thomas RG, Walter S, Trojanowski JQ, Shaw LM, Beckett LA, Jack CR Jr, Jagust W, Toga AW, Saykin AJ, Morris JC, Green RC, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2010 May;6(3):239-46. doi: 10.1016/j.jalz.2010.03.006. Review.

PMID:
20451872
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

[The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].

Croisile B, Auriacombe S, Etcharry-Bouyx F, Vercelletto M; National Institute on Aging (u.s.); Alzheimer Association.

Rev Neurol (Paris). 2012 Jun;168(6-7):471-82. doi: 10.1016/j.neurol.2011.11.007. Epub 2012 May 12. Review. French.

PMID:
22579080
[PubMed - indexed for MEDLINE]
6.

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.

Hampel H, Bürger K, Teipel SJ, Bokde AL, Zetterberg H, Blennow K.

Alzheimers Dement. 2008 Jan;4(1):38-48. doi: 10.1016/j.jalz.2007.08.006. Epub 2007 Dec 21. Review.

PMID:
18631949
[PubMed - indexed for MEDLINE]
7.

Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects.

Trojanowski JQ, Vandeerstichele H, Korecka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter WZ, Weiner MW, Jack CR Jr, Jagust W, Toga AW, Lee VM, Shaw LM; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2010 May;6(3):230-8. doi: 10.1016/j.jalz.2010.03.008. Review.

PMID:
20451871
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease.

Arnáiz E, Almkvist O.

Acta Neurol Scand Suppl. 2003;179:34-41. Review.

PMID:
12603249
[PubMed - indexed for MEDLINE]
9.

Vitamin E for Alzheimer's disease and mild cognitive impairment.

Isaac MG, Quinn R, Tabet N.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD002854. doi: 10.1002/14651858.CD002854.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;11:CD002854.

PMID:
18646084
[PubMed - indexed for MEDLINE]
10.

[Mild Cognitive Impairment or pre-demential Alzheimer's disease?].

Sarazin M, Dubois B.

Rev Neurol (Paris). 2002;158(10 Suppl):S30-4. Review. French.

PMID:
12529583
[PubMed - indexed for MEDLINE]
11.

Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage.

Drago V, Babiloni C, Bartrés-Faz D, Caroli A, Bosch B, Hensch T, Didic M, Klafki HW, Pievani M, Jovicich J, Venturi L, Spitzer P, Vecchio F, Schoenknecht P, Wiltfang J, Redolfi A, Forloni G, Blin O, Irving E, Davis C, Hårdemark HG, Frisoni GB.

J Alzheimers Dis. 2011;26 Suppl 3:159-99. doi: 10.3233/JAD-2011-0043. Review.

PMID:
21971460
[PubMed - indexed for MEDLINE]
12.

Category cued recall following controlled encoding as a neuropsychological tool in the diagnosis of Alzheimer's disease: a review of the evidence.

Carlesimo GA, Perri R, Caltagirone C.

Neuropsychol Rev. 2011 Mar;21(1):54-65. doi: 10.1007/s11065-010-9153-7. Epub 2010 Nov 18. Review.

PMID:
21086049
[PubMed - indexed for MEDLINE]
13.

Early identification of cognitive deficits: preclinical Alzheimer's disease and mild cognitive impairment.

Small BJ, Gagnon E, Robinson B.

Geriatrics. 2007 Apr;62(4):19-23. Review.

PMID:
17408315
[PubMed - indexed for MEDLINE]
14.

[Conversion from MCI (Mild Cognitive Impairment) to Alzheimer's disease: diagnostic options and predictors].

Defranceso M, Schocke M, Messner HJ, Deisenhammer EA, Hinterhuber H, Marksteiner J, Weiss EM.

Neuropsychiatr. 2010;24(2):88-98. Review. German.

PMID:
20605004
[PubMed - indexed for MEDLINE]
15.

Preclinical Alzheimer's disease: diagnosis and prediction of progression.

Chong MS, Sahadevan S.

Lancet Neurol. 2005 Sep;4(9):576-9. Review.

PMID:
16109364
[PubMed - indexed for MEDLINE]
16.

Vitamin E for Alzheimer's dementia and mild cognitive impairment.

Farina N, Isaac MG, Clark AR, Rusted J, Tabet N.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD002854. doi: 10.1002/14651858.CD002854.pub3. Review.

PMID:
23152215
[PubMed - indexed for MEDLINE]
17.

[Awareness of deficits and anosognosia in Alzheimer's disease].

Antoine C, Antoine P, Guermonprez P, Frigard B.

Encephale. 2004 Nov-Dec;30(6):570-7. Review. French.

PMID:
15738860
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk